Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Nicolas M Van Mieghem Added: 3 months ago
Stay at the forefront of cardiovascular medicine with our comprehensive video collection from the American Heart Association's Scientific Sessions 2025. Access expert analysis of the most impactful late-breaking trials and featured science shaping clinical practice.Late-Breaker Discussions: Watch Dr Harriette Van Spall break down pivotal clinical trial data and explore its implications for… View more
Author(s): Jasper J Brugts Added: 8 months ago
ESC HF 25 - TITRATE-HF shows 65% of patients with de novo heart failure receive guideline recommended medical therapy at 6 months in the Netherlands.Dr Jasper Brugts (Erasmus University Medical Centre, NL) joins us to discuss the outcomes from the TITRATE-HF study, which investigated adherence to the 2021 ESC guideline reccommendations for patients with heart failure with reduced ejecton fraction… View more
Job title: Robert Wood Johnson Clinical Scholar
Author(s): Dipti Itchhaporia , Valentin Fuster Added: 1 year ago
In this exclusive episode of the "Innovations in Cardiology" podcast series, host Dr Dipti Itchhaporia, past president of the American College of Cardiology, delves into the latest advancements in cardiovascular health. She is joined by Dr Valentin Fuster, a pioneer in the field, who shares invaluable insights into the impact of biological ageing, the connection between the heart and brain, and… View more
Job title: Professor of Medicine and Director of the Physician-Scientist Fellowship
Author(s): Vijay Chopra, Javed Butler, Dinesh Khullar ,et al Start date: Nov 17, 2025
Breakthrough Mineralocorticoid Receptor Antagonists in Cardiovascular Care brings together renowned cardiovascular experts Dr Vijay Chopra, Dr Javed Butler, Dr Dinesh Khullar, and Prof John McMurray to address critical challenges in heart failure management and hypertension treatment. This comprehensive session explores innovative approaches to mineralocorticoid receptor antagonist (MRA) therapy,… View more
Author(s): Ambarish Pandey Added: 3 months ago
AHA Scientific Sessions 2025 – Dr Ambarish Pandey (University of Texas Southwestern Medical Center, US) presents results from the POLY-HF trial (NCT04633005), evaluating a polypill strategy combining multiple evidence-based medications for heart failure with reduced ejection fraction.This single-center randomized trial enrolled 212 patients with HFrEF (ejection fraction ≤40%) who were not… View more
Author(s): Giuseppe Rosano , John R Teerlink , Koichiro Kinugawa Added: 9 months ago
This comprehensive video series has been designed to enhance your understanding of heart failure (HF) management. Through expert discussions, we explore the real-world adoption of novel guideline-directed medical therapies (GDMTs) and their impact on patient care. We also delve into the benefits of natriuretic peptide (NP) testing, highlighting how it aids in more accurate and rapid diagnosis,… View more
Author(s): Steven E Nissen Added: 1 year ago
ACC.24 — Investigator, Dr Steven Nissen (Cleveland Clinic, US) joins us onsite to discuss the findings of a trial designed to evaluate the extent to which participants could safely and effectively select, purchase and use rosuvastatin calcium 5mg for a 6-month trial period (NCT04964544).The TACTiC trial is a single-arm interventional, phase III self-selection and actual use study implementing a… View more